حآفرین
ریل پرداز نو آفرین
سود 3 Months :
| سهامدار | نوع معامله | حجم معامله | زمان انتشار | منبع |
|---|---|---|---|---|
 شرکت سرمایه گذاری دارویی بهیان پرمون | خرید | 0.515 میلیون | 9 hour ago |  شرکت مدیریت فناوری سازمان بورس |
شرکت ریل پروازتندرخاورمیانه م. آزادانزلی | خرید | 41.208 میلیون | 5/7/2025 | شرکت مدیریت فناوری سازمان بورس |
شرکت تدبیرروشن تجارت منطقه آزادانزلی | خرید | 330.191 میلیون | 5/7/2025 | شرکت مدیریت فناوری سازمان بورس |
شرکت سرمایه گذاری راهبردمبین ایرانیان | خرید | 1.500 میلیون | 2/1/2025 | شرکت مدیریت فناوری سازمان بورس |
شرکت ارزش آفرینان فدک | خرید | 74.360 میلیون | 1/27/2025 | شرکت مدیریت فناوری سازمان بورس |
پیامهای حآفرین
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company bought 0.515 million shares of Hafarin on 09/22/1404 and currently has 1.78% of Hafarin shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company bought 3.871 million shares of Hafarin on 09/19/1404 and currently has 1.774% of Hafarin's shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company purchased 1.228 million shares of Hafarin on 09/18/1404 and currently has 1.734% of Hafarin's shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company bought 0.383 million shares of Hafarin on 09/17/1404 and currently has 1.721% of Hafarin shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company purchased 12.816 million shares of Hafarin on 09/10/1404 and currently has 1.693% of Hafarin's shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company purchased 0.827 million shares of Hafarin on 09/09/1404 and currently has 1.558% of Hafarin shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company bought 3.680 million Haafrin shares on 09/08/1404 and currently has 1.549% of Haafrin shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company purchased 0.376 million shares of Hafarin on 09/01/1404 and currently has 1.5% of Hafarin shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company bought 0.376 million shares of Hafarin on 08/28/1404 and currently has 1.5% of Hafarin shares in its stock portfolio.
شرکت سرمایه گذاری دارویی بهیان پرمون
Behian Permon Pharmaceutical Investment Company bought 0.228 million shares of Hafarin on 08/27/1404 and currently has 1.496% of Hafarin shares in its stock portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.